Dexamethasone Alters the Hepatic Inflammatory Cellular Profile Without Changes in Matrix Degradation During Liver Repair Following Biliary Decompression

Journal of Surgical Research

Volumn 156, Issue 2, 2009, Pages 231-239

  Muratore, Christopher S ^a   Harty, Mark W ^a   Papa, Elaine F ^a   Tracy Jr , Thomas F ^a  

^a HASBRO CHILDREN'S HOSPITAL   (United States)

Author keywords

biliary atresia; cholestatic injury; dexamethasone; hepatic fibrosis; inflammation; matrix metalloproteinase; neutrophil

Indexed keywords

COLLAGENASE 3; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; DEXAMETHASONE; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 6; MATRIX METALLOPROTEINASE 14; NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DECOMPRESSION SURGERY; GENE EXPRESSION; HEPATITIS; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LIVER SURGERY; MALE; MORPHOMETRICS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BILE DUCTS; BILIARY ATRESIA; CHOLESTASIS; COLLAGEN; CYTOKINES; DECOMPRESSION, SURGICAL; DEXAMETHASONE; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX PROTEINS; KUPFFER CELLS; LIVER; LIVER CIRRHOSIS; MACROPHAGES; MALE; NEUTROPHILS; RATS;

EID: 70349163634     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.04.016     Document Type: Article

References (25)

1. Nio M., and Ohi R. Biliary atresia. Semin Pediatr Surg 9 (2000) 177-186
2. Ahmed A.F., Ohtani H., Nio M., Funaki N., Shimaoka S., Nagura H., and Ohi R. CD8 + T cells infiltrating into bile ducts in biliary atresia do not appear to function as cytotoxic T cells: a clinicopathological analysis. J Pathol 193 (2001) 383-389
3. Ohya T., Fujimoto T., Shimomura H., and Miyano T. Degeneration of intrahepatic bile duct with lymphocyte infiltration into biliary epithelial cells in biliary atresia. J Pediatr Surg 30 (1995) 515-518
4. Haas J.E. Bile duct and liver pathology in biliary atresia. World J Surg 2 (1978) 561-569
5. Altman R.P., Lilly J.R., Greenfeld J., Weinberg A., van Leeuwen K., and Flanigan L. A multivariable risk factor analysis of the portoenterostomy (Kasai) procedure for biliary atresia: twenty-five years of experience from two centers. Ann Surg 226 (1997) 348-353 discussion 353-345
6. Tracy Jr. T.F., Dillon P., Fox E.S., Minnick K., and Vogler C. The inflammatory response in pediatric biliary disease: macrophage phenotype and distribution. J Pediatr Surg 31 (1996) 121-125 discussion 125-126
7. Muraji T., and Higashimoto Y. The improved outlook for biliary atresia with corticosteroid therapy. J Pediatr Surg 32 (1997) 1103-1106 discussion 1106-1107
8. Nietgen G.W., Vacanti J.P., and Perez-Atayde A.R. Intrahepatic bile duct loss in biliary atresia despite portoenterostomy: a consequence of ongoing obstruction?. Gastroenterology 102 (1992) 2126-2133
9. Lunzmann K., and Schweizer P. The influence of cholangitis on the prognosis of extrahepatic biliary atresia. Eur J Pediatr Surg 9 (1999) 19-23
10. Meyers R.L., Book L.S., O'Gorman M.A., Jackson W.D., Black R.E., Johnson D.G., and Matlak M.E. High-dose steroids, ursodeoxycholic acid, and chronic intravenous antibiotics improve bile flow after Kasai procedure in infants with biliary atresia. J Pediatr Surg 38 (2003) 406-411
11. Davenport M., Stringer M.D., Tizzard S.A., McClean P., Mieli-Vergani G., and Hadzic N. Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia. Hepatology 46 (2007) 1821-1827
12. Muraji T., Nio M., Ohhama Y., Hashimoto T., Iwanaka T., Takamatsu H., Ohnuma N., et al. Postoperative corticosteroid therapy for bile drainage in biliary atresia-a nationwide survey. J Pediatr Surg 39 (2004) 1803-1805
13. Stringer M.D., Davison S.M., Rajwal S.R., and McClean P. Kasai portoenterostomy: 12-year experience with a novel adjuvant therapy regimen. J Pediatr Surg 42 (2007) 1324-1328
14. Escobar M.A., Jay C.L., Brooks R.M., West K.W., Rescorla F.J., Molleston J.P., and Grosfeld J.L. Effect of corticosteroid therapy on outcomes in biliary atresia after Kasai portoenterostomy. J Pediatr Surg 41 (2006) 99-103 discussion 199-103
15. Harty M.W., Papa E.F., Huddleston H.M., Young E., Nazareth S., Riley C.A., Ramm G.A., et al. Hepatic macrophages promote the neutrophil-dependent resolution of fibrosis in repairing cholestatic rat livers. Surgery 143 (2008) 667-678
16. Harty M.W., Huddleston H.M., Papa E.F., Puthawala T., Tracy A.P., Ramm G.A., Gehring S., et al. Repair after cholestatic liver injury correlates with neutrophil infiltration and matrix metalloproteinase 8 activity. Surgery 138 (2005) 313-320
17. Melgert B.N., Weert B., Schellekens H., Meijer D.K., and Poelstra K. The pharmacokinetic and biological activity profile of dexamethasone targeted to sinusoidal endothelial and Kupffer cells. J Drug Target 11 (2003) 1-10
18. Roggin K.K., Papa E.F., Kurkchubasche A.G., and Tracy Jr. T.F. Kupffer cell inactivation delays repair in a rat model of reversible biliary obstruction. J Surg Res 90 (2000) 166-173
19. Posner M.C., Burt M.E., Stone M.D., Han B.L., Warren R.S., Vydelingum N.A., and Brennan M.F. A model of reversible obstructive jaundice in the rat. J Surg Res 48 (1990) 204-210
20. Moloney W.C., McPherson K., and Fliegelman L. Esterase activity in leukocytes demonstrated by the use of naphthol AS-D chloroacetate substrate. J Histochem Cytochem 8 (1960) 200-207
21. Damoiseaux J.G., Dopp E.A., Calame W., Chao D., MacPherson G.G., and Dijkstra C.D. Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology 83 (1994) 140-147
22. Dijkstra C.D., Dopp E.A., van den Berg T.K., and Damoiseaux J.G. Monoclonal antibodies against rat macrophages. J Immunol Methods 174 (1994) 21-23
23. Rozen S., and Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132 (2000) 365-386
24. Dillon P., Belchis D., Tracy T., Cilley R., Hafer L., and Krummel T. Increased expression of intercellular adhesion molecules in biliary atresia. Am J Pathol 145 (1994) 263-267
25. Dillon P.W., Owings E., Cilley R., Field D., Curnow A., and Georgeson K. Immunosuppression as adjuvant therapy for biliary atresia. J Pediatr Surg 36 (2001) 80-85